Immediate effects of rest periods on balance control in patients after stroke. A randomized controlled pilot trial

Early-phase dose articulation trials are underutilized for post-stroke motor recovery: A systematic scoping review

BACKGROUND

To enable development of effective interventions, there is a need to complete systematic early-phase dose articulation research. This scoping review aimed to synthesize dose articulation research of behavioral motor interventions for stroke recovery.

METHODS

MEDLINE and EMBASE were systematically searched for dose articulation studies. Preclinical experiments and adult clinical trials were classified based on the discovery pipeline and analyzed to determine which dose dimensions were articulated (time, scheduling or intensity) and how they were investigated (unidimensional vs multidimensional approach). Reporting of dose, safety and efficacy outcomes were summarized. The intervention description, risk of bias, and quality was appraised.

RESULTS

We included 41 studies: 3 of preclinical dose preparation (93 rodents), 2 Phase I dose ranging (21 participants), 9 Phase IIA dose screening (198 participants), and 27 Phase IIB dose finding (1879 participants). All studies adopted a unidimensional approach. Time was the most frequent dimension investigated (53%), followed by intensity (29%), and scheduling (18%). Overall, 95% studies reported an efficacy outcome; however, only 65% reported dose and 45% reported safety. Across studies, 61% were at high risk of bias, and the average percentage reporting of intervention description and quality was 61% and 67%, respectively.

CONCLUSION

This review highlights a need to undertake more high-quality, early-phase studies that systematically articulate intervention doses from a multidimensional perspective in the field of behavioral motor stroke recovery. To address this gap, we need to invest in adapting early phase trial designs, especially Phase I, to support multidimensional dose articulation.

Walking with rhythmic auditory stimulation in chronic patients after stroke: A pilot randomized controlled trial

OBJECTIVES

There is a lack of studies that evaluate the effects of different gait training (GT) interventions for patients after stroke in an outpatient setting. The aim of the present trial therefore was to evaluate the effects of two different outpatient GT programmes after chronic stroke.

METHODS

We randomly allocated patients into two groups of either a 4-week overground GT with rhythmic auditory stimulation (RAS, n = 6) of 30 min, three times a week over 4 weeks or an overground GT without RAS (GT, n = 6) with same duration and intensity. Primary outcomes were walking velocity and capacity; secondary outcomes were the Berg Balance Scale (BBS) and stride length before and after interventions and at 12 weeks follow-up.

RESULTS

Twelve patients after stroke (nine females; mean [SD] age 67 [9] years; duration of illness 67 [69] months; all left-sided strokes) were included. Patients improved their walking velocity from baseline until the end of GT (RAS: median difference 0.05 m/s [interquartile range, IQR 0.06] and GT: 0.12 m/s [0.29]) and walking capacity (RAS: median difference 14 m [IQR 14] and GT: 41 m [79]). However, RAS and GT did not differ significantly (p = .30 and p = .30, respectively). Patients improved from baseline until the end of intervention in BBS (RAS: median difference 4 points [IQR 4] and GT: 1 point [3]) and stride length (RAS: median difference 6.3 cm [IQR 12.1] and GT: 5.5 cm [8.8]). However, BBS and stride length did not differ significantly between groups (p = .08 and p = .58, respectively).

CONCLUSION

Walking with rhythmic auditory stimulation in chronic patients after stroke does not provide a beneficial effect on walking when compared with walking without rhythmic auditory stimulation.